This paper presents a power-efficient Ultra Low Voltage (ULV) Fully-Differential (FD) Digital-Based Operational Transconductance Amplifier for Biomedical signal processing (BioDIGOTA), which digitally processes biological analog signals using CMOS standard-cells. Post-layout simulations, including parasitic effects in 180nm CMOS technology, show that BioDIGOTA consumes only 144 nW at 300 mV of supply voltage while driving a 20pF capacitive load, with a power efficiency factor (PEF) lower than 1. The layout uses 0.03 mm2 of the total silicon area, excluding I/0 pads. The proposed BioDIGOTA proves that digital-based analog design can be adopted in biomedical signal amplifiers, lowering the total silicon area by 2.3X times compared to the current state of the art landscape while keeping reasonable power and system performance.

A 300mV-Supply, 144nW-Power, 0.03mm2-Area, 0.2-PEF Digital-Based Biomedical Signal Amplifier in 180nm CMOS / Pedro, Toledo; Klimach, Hamilton; Bampi, Sergio; Crovetti, PAOLO STEFANO. - STAMPA. - (2021). (Intervento presentato al convegno 2021 IEEE International Symposium on Medical Measurements and Applications (MeMeA) tenutosi a Lausanne, Switzerland nel 23-25 June 2021) [10.1109/MeMeA52024.2021.9478709].

A 300mV-Supply, 144nW-Power, 0.03mm2-Area, 0.2-PEF Digital-Based Biomedical Signal Amplifier in 180nm CMOS

Pedro Toledo;Paolo Crovetti
2021

Abstract

This paper presents a power-efficient Ultra Low Voltage (ULV) Fully-Differential (FD) Digital-Based Operational Transconductance Amplifier for Biomedical signal processing (BioDIGOTA), which digitally processes biological analog signals using CMOS standard-cells. Post-layout simulations, including parasitic effects in 180nm CMOS technology, show that BioDIGOTA consumes only 144 nW at 300 mV of supply voltage while driving a 20pF capacitive load, with a power efficiency factor (PEF) lower than 1. The layout uses 0.03 mm2 of the total silicon area, excluding I/0 pads. The proposed BioDIGOTA proves that digital-based analog design can be adopted in biomedical signal amplifiers, lowering the total silicon area by 2.3X times compared to the current state of the art landscape while keeping reasonable power and system performance.
2021
978-1-6654-1914-7
File in questo prodotto:
File Dimensione Formato  
MEMEA_2021__invited_final.pdf

accesso aperto

Descrizione: Post-print non editoriale
Tipologia: 2. Post-print / Author's Accepted Manuscript
Licenza: PUBBLICO - Tutti i diritti riservati
Dimensione 4.46 MB
Formato Adobe PDF
4.46 MB Adobe PDF Visualizza/Apri
Crovetti-A300mV.pdf

non disponibili

Tipologia: 2a Post-print versione editoriale / Version of Record
Licenza: Non Pubblico - Accesso privato/ristretto
Dimensione 5.81 MB
Formato Adobe PDF
5.81 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11583/2909436